BR100 Increased By (1.32%)
BR30 Increased By (1.33%)
KSE100 Increased By (1.37%)
KSE30 Increased By (1.47%)
AGHA 7.87 Increased By ▲ 0.12 (1.55%)
BECO 5.21 Increased By ▲ 0.02 (0.39%)
BML 59.45 Increased By ▲ 0.79 (1.35%)
BOP 34.37 Increased By ▲ 0.68 (2.02%)
CNERGY 10.92 Increased By ▲ 0.31 (2.92%)
CSIL 5.31 Increased By ▲ 0.01 (0.19%)
FCCL 54.34 Increased By ▲ 0.60 (1.12%)
FFL 16.83 Increased By ▲ 0.37 (2.25%)
FNEL 1.21 Decreased By ▼ -0.01 (-0.82%)
KEL 7.43 Increased By ▲ 0.15 (2.06%)
KOSM 5.72 Increased By ▲ 0.08 (1.42%)
LOTCHEM 30.02 Increased By ▲ 0.37 (1.25%)
MLCF 97.45 Increased By ▲ 1.09 (1.13%)
NBP 205.70 Increased By ▲ 2.17 (1.07%)
NCPL 58.11 Increased By ▲ 1.26 (2.22%)
NPL 69.42 Increased By ▲ 2.11 (3.13%)
OGDC 321.25 Increased By ▲ 3.03 (0.95%)
PACE 10.76 Increased By ▲ 0.13 (1.22%)
PAEL 42.54 Increased By ▲ 0.77 (1.84%)
PIBTL 17.16 Increased By ▲ 0.35 (2.08%)
PPL 223.78 Increased By ▲ 3.61 (1.64%)
PRL 52.84 Increased By ▲ 3.79 (7.73%)
PTC 71.10 Increased By ▲ 1.09 (1.56%)
SSGC 29.65 Increased By ▲ 0.51 (1.75%)
TBL 9.78 Increased By ▲ 0.01 (0.1%)
TELE 8.96 Increased By ▲ 0.14 (1.59%)
TPL 17.40 Increased By ▲ 0.23 (1.34%)
TPLP 12.86 Increased By ▲ 0.35 (2.8%)
TREET 22.90 Increased By ▲ 0.31 (1.37%)
TRG 60.60 Increased By ▲ 0.38 (0.63%)
By

THE HAGUE: Two doses of Covid vaccine appear to provide protection against the rapidly spreading Delta variant, the European Medicines Agency said Thursday. The upbeat assessment came as the World Health Organization warned that the coronavirus variant first spotted in India could fuel a new wave of cases in Europe.

The EMA's head of vaccine strategy, Marco Cavaleri, said the Amsterdam-based watchdog was "aware of concerns caused by the rapid spread of the Delta variant.

"Right now it seems that the four vaccines approved in the European Union are protecting against all the strains circulating in Europe, including the Delta variant," he said.

"Emerging data from real world evidence are showing that two doses of vaccines are protective against the Delta variant."

Lab tests also showed that antibodies from the vaccines were able to neutralise Delta "so these are very reassuring news."

Four vaccines are currently approved for use in the EU: Pfizer/BioNTech, Moderna, AstraZeneca and Johnson & Johnson. But while the EU has been stepping up its vaccination programme, the WHO warned that cases are on the rise again after two months of decline.

The WHO said the reversal came as the Delta variant was overtaking the original Alpha variant that emerged in Britain "very quickly".

The EMA's Cavaleri said the regulator urged manufacturers to keep checking that their jabs were effective against all new variants of the disease including the so-called 'Delta Plus'.

"There are a number of variants that have been emerging over the last months, and we expect more to come over," Cavaleri said.

"Now there is the so-called Delta Plus variant, which is the Delta variant with an additional mutation in the spike protein, that is also important and we need to check that as well."

Comments

Comments are closed for this article.